Early use of factor VIIa in cardiac surgery is associated with lower rates of blood transfusions without impact on outcome

Bleeding after cardiac surgery is a common state, associated with adverse effects. Factor VIIa is a recombinant factor able to restore blood coagulation without significant adverse effects. We aimed to evaluate whether the early use of factor VIIa reduces bleeding and the rates of transfusion.